Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5

Reference

Title : Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications - Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5
Author(s) : Fagnani F , Lafuma A , Pechevis M , Rigaud AS , Traykov L , Seux ML , Forette F
Ref : Dementia & Geriatric Cognitive Disorders , 17 :5 , 2004
Abstract : Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5
ESTHER : Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5
PubMedSearch : Fagnani_2004_Dement.Geriatr.Cogn.Disord_17_5
PubMedID: 14560059

Related information

Citations formats

Fagnani F, Lafuma A, Pechevis M, Rigaud AS, Traykov L, Seux ML, Forette F (2004)
Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications
Dementia & Geriatric Cognitive Disorders 17 :5

Fagnani F, Lafuma A, Pechevis M, Rigaud AS, Traykov L, Seux ML, Forette F (2004)
Dementia & Geriatric Cognitive Disorders 17 :5